Psyllid ID: psy461
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 507 | ||||||
| 42662203 | 479 | tyramine receptor [Bombyx mori] | 0.840 | 0.889 | 0.517 | 1e-140 | |
| 13173421 | 477 | putative octopamine receptor [Mamestra b | 0.846 | 0.899 | 0.509 | 1e-139 | |
| 112984406 | 479 | octopamine receptor [Bombyx mori] gi|249 | 0.840 | 0.889 | 0.515 | 1e-139 | |
| 223673360 | 477 | tyramine/octopamine receptor [Agrotis ip | 0.846 | 0.899 | 0.507 | 1e-139 | |
| 2495005 | 477 | RecName: Full=Octopamine receptor gi|119 | 0.848 | 0.901 | 0.516 | 1e-138 | |
| 210076544 | 478 | Oct/Tyr receptor [Spodoptera littoralis] | 0.846 | 0.897 | 0.508 | 1e-138 | |
| 198463614 | 625 | GA20386 [Drosophila pseudoobscura pseudo | 0.883 | 0.716 | 0.516 | 1e-137 | |
| 195172881 | 621 | GL25423 [Drosophila persimilis] gi|19411 | 0.883 | 0.721 | 0.516 | 1e-137 | |
| 195128241 | 611 | GI13571 [Drosophila mojavensis] gi|19392 | 0.932 | 0.774 | 0.507 | 1e-136 | |
| 3024246 | 484 | RecName: Full=Tyramine receptor 1; AltNa | 0.854 | 0.894 | 0.561 | 1e-134 |
| >gi|42662203|dbj|BAD11157.1| tyramine receptor [Bombyx mori] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 258/499 (51%), Positives = 336/499 (67%), Gaps = 73/499 (14%)
Query: 20 VCVEEEKQYYPSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRI 79
VC ++ YPS+F I +VPEWEAI T I L+ +II T++GNI+V++SVFTYKPLRI
Sbjct: 30 VCAVADEPKYPSSF--GISLAVPEWEAICTAIILTMIIISTVVGNILVILSVFTYKPLRI 87
Query: 80 VQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCA 139
VQNFFIVSLAVADLTVAI VLPL++ Y + G+W+FGI +CK+WLT D++CCT+SILNLCA
Sbjct: 88 VQNFFIVSLAVADLTVAILVLPLNVAYSILGQWVFGIYVCKMWLTCDIMCCTSSILNLCA 147
Query: 140 IALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTPCQ 199
IALDRYWAITDP+ YAQ+RT++RV+ MI VW+LS +ISSPPL+GWNDWPEVFE DTPC+
Sbjct: 148 IALDRYWAITDPINYAQKRTLERVLFMIGIVWILSLVISSPPLLGWNDWPEVFEPDTPCR 207
Query: 200 LTQQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVK--------Q 251
LT Q G+V++SS GSF+IPL IMT+VY EI+LATKKRLRDRAKA+K++ + +
Sbjct: 208 LTSQPGFVIFSSSGSFYIPLVIMTVVYFEIYLATKKRLRDRAKATKISTISSGRNKYETK 267
Query: 252 TTLHNVQKEVQSPLEPES------ISSENDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSF 305
+ N Q V S P + +EN+ K K +KK K++ K++ ++N
Sbjct: 268 ESDPNDQDSVSSDANPNEHQGSTRLVAENEKKHRTRKLTPKKKPKRRYWSKDDKSHNK-L 326
Query: 306 LRPVLINEDSMTDI------QDLSSSSNKIAARNDNMGEFVHINNNETTFTNKTISDDIS 359
+ P+L NE+S+TDI ++ SS SN DNM E
Sbjct: 327 IIPILSNENSVTDIGENLENRNTSSESNSKETHEDNMIEITE------------------ 368
Query: 360 LASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKI 419
A +K K+P T V QFIEEKQ+I
Sbjct: 369 AAPVKIQKRPKQNQ--------------------------------TNAVYQFIEEKQRI 396
Query: 420 SLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGIN 479
SL++ERRAARTLGIIMGVFV CWLPFF++Y+ +PFC +CC+S++ INFITWLGY+NS +N
Sbjct: 397 SLTRERRAARTLGIIMGVFVVCWLPFFVIYLVIPFCVSCCLSNKFINFITWLGYVNSALN 456
Query: 480 PIIYTIFNLDFRKSFKRLL 498
P+IYTIFN+DFR++FK+LL
Sbjct: 457 PLIYTIFNMDFRRAFKKLL 475
|
Source: Bombyx mori Species: Bombyx mori Genus: Bombyx Family: Bombycidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|13173421|gb|AAK14402.1|AF343878_1 putative octopamine receptor [Mamestra brassicae] | Back alignment and taxonomy information |
|---|
| >gi|112984406|ref|NP_001037504.1| octopamine receptor [Bombyx mori] gi|2495004|sp|Q17232.1|OAR_BOMMO RecName: Full=Octopamine receptor gi|1197192|emb|CAA64865.1| octopamine receptor [Bombyx mori] | Back alignment and taxonomy information |
|---|
| >gi|223673360|gb|ACN12797.1| tyramine/octopamine receptor [Agrotis ipsilon] | Back alignment and taxonomy information |
|---|
| >gi|2495005|sp|Q25188.1|OAR_HELVI RecName: Full=Octopamine receptor gi|1197330|emb|CAA64864.1| octopamine receptor [Heliothis virescens] | Back alignment and taxonomy information |
|---|
| >gi|210076544|gb|ACJ06651.1| Oct/Tyr receptor [Spodoptera littoralis] | Back alignment and taxonomy information |
|---|
| >gi|198463614|ref|XP_001352884.2| GA20386 [Drosophila pseudoobscura pseudoobscura] gi|198151336|gb|EAL30385.2| GA20386 [Drosophila pseudoobscura pseudoobscura] | Back alignment and taxonomy information |
|---|
| >gi|195172881|ref|XP_002027224.1| GL25423 [Drosophila persimilis] gi|194113045|gb|EDW35088.1| GL25423 [Drosophila persimilis] | Back alignment and taxonomy information |
|---|
| >gi|195128241|ref|XP_002008573.1| GI13571 [Drosophila mojavensis] gi|193920182|gb|EDW19049.1| GI13571 [Drosophila mojavensis] | Back alignment and taxonomy information |
|---|
| >gi|3024246|sp|Q25321.1|OAR1_LOCMI RecName: Full=Tyramine receptor 1; AltName: Full=Tyr-Loc1 gi|871405|emb|CAA49268.1| monophenolic amine tyramine [Locusta migratoria migratorioides] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 507 | ||||||
| FB|FBgn0004514 | 601 | Oct-TyrR "Octopamine-Tyramine | 0.465 | 0.392 | 0.616 | 4.5e-122 | |
| WB|WBGene00004777 | 455 | ser-2 [Caenorhabditis elegans | 0.408 | 0.454 | 0.452 | 3.6e-78 | |
| UNIPROTKB|O02213 | 455 | ser-2 "Tyramine receptor ser-2 | 0.408 | 0.454 | 0.452 | 3.6e-78 | |
| UNIPROTKB|E1BZQ1 | 377 | HTR1D "Uncharacterized protein | 0.414 | 0.557 | 0.398 | 8.7e-67 | |
| UNIPROTKB|F1NAZ2 | 422 | HTR1A "Uncharacterized protein | 0.408 | 0.490 | 0.394 | 3.7e-66 | |
| UNIPROTKB|F6Q2H9 | 422 | HTR1A "Uncharacterized protein | 0.441 | 0.530 | 0.373 | 4.8e-66 | |
| ZFIN|ZDB-GENE-071203-1 | 398 | htr1aa "5-hydroxytryptamine (s | 0.390 | 0.497 | 0.407 | 7.7e-66 | |
| UNIPROTKB|Q98998 | 408 | htr1a "5-hydroxytryptamine rec | 0.429 | 0.534 | 0.382 | 9.8e-66 | |
| UNIPROTKB|F1SKV3 | 422 | HTR1A "Uncharacterized protein | 0.435 | 0.523 | 0.378 | 2.6e-65 | |
| UNIPROTKB|P08908 | 422 | HTR1A "5-hydroxytryptamine rec | 0.437 | 0.526 | 0.377 | 2.6e-65 |
| FB|FBgn0004514 Oct-TyrR "Octopamine-Tyramine receptor" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 148/240 (61%), Positives = 190/240 (79%)
Query: 37 IEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVA 96
++ +VPEWEA++T + LS +I+ TIIGNI+V++SVFTYKPLRIVQNFFIVSLAVADLTVA
Sbjct: 100 LQLAVPEWEALLTALVLSVIIVLTIIGNILVILSVFTYKPLRIVQNFFIVSLAVADLTVA 159
Query: 97 IFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQ 156
+ VLP ++ Y + GRW FGI +CK+WLT DVLCCT+SILNLCAIALDRYWAITDP+ YAQ
Sbjct: 160 LLVLPFNVAYSILGRWEFGIHLCKLWLTCDVLCCTSSILNLCAIALDRYWAITDPINYAQ 219
Query: 157 QRTIKRVMMMIMYVWXXXXXXXXXXXXGWNDWPEVFEADTPCQLTQQRGYVVYSSLGSFF 216
+RT+ RV+++I VW GWNDWP+ F + TPC+LT QRGYV+YSSLGSFF
Sbjct: 220 KRTVGRVLLLISGVWLLSLLISSPPLIGWNDWPDEFTSATPCELTSQRGYVIYSSLGSFF 279
Query: 217 IPLAIMTLVYVEIFLATKKRLRDRAKASKLNIV--KQTTLHNVQKEVQSPLEPESISSEN 274
IPLAIMT+VY+EIF+AT++RLR+RA+A+KLN + K T L + SP+ + S++
Sbjct: 280 IPLAIMTIVYIEIFVATRRRLRERARANKLNTIALKSTELEPMANS--SPVAASNSGSKS 337
|
|
| WB|WBGene00004777 ser-2 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|O02213 ser-2 "Tyramine receptor ser-2" [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|E1BZQ1 HTR1D "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1NAZ2 HTR1A "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F6Q2H9 HTR1A "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-071203-1 htr1aa "5-hydroxytryptamine (serotonin) receptor 1A a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q98998 htr1a "5-hydroxytryptamine receptor 1A" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1SKV3 HTR1A "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P08908 HTR1A "5-hydroxytryptamine receptor 1A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 507 | |||
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 2e-44 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 1e-16 | |
| PHA03087 | 335 | PHA03087, PHA03087, G protein-coupled chemokine re | 7e-13 | |
| PHA02638 | 417 | PHA02638, PHA02638, CC chemokine receptor-like pro | 4e-11 | |
| PHA02834 | 323 | PHA02834, PHA02834, chemokine receptor-like protei | 8e-06 | |
| PHA03235 | 409 | PHA03235, PHA03235, DNA packaging protein UL33; Pr | 0.004 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 62/173 (35%), Positives = 93/173 (53%), Gaps = 5/173 (2%)
Query: 71 VFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCC 130
+ K LR N F+++LAVADL + + P +L Y + G W FG +CK+ V+
Sbjct: 3 ILRTKKLRTPTNIFLLNLAVADLLFLLTLPPWALYYLVGGDWPFGDALCKLVGFLFVVNG 62
Query: 131 TASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPE 190
ASIL L AI++DRY AI PL Y + RT +R ++I+ VW+L+ L+S PPL+
Sbjct: 63 YASILLLTAISIDRYLAIVHPLRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLRTV 122
Query: 191 VFEADTPCQLT-----QQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLR 238
T C + +R Y + S+L F +PL ++ + Y I +KR R
Sbjct: 123 EEGNVTTCLIDFPEESTKRSYTLLSTLLGFVLPLLVILVCYTLILRTLRKRAR 175
|
This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
| >gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|223017 PHA03235, PHA03235, DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 507 | |||
| KOG4220|consensus | 503 | 100.0 | ||
| KOG4219|consensus | 423 | 100.0 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 100.0 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 100.0 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 100.0 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 100.0 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 100.0 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 100.0 | |
| KOG2087|consensus | 363 | 99.93 | ||
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 99.9 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 99.87 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 99.83 | |
| PF05296 | 303 | TAS2R: Mammalian taste receptor protein (TAS2R); I | 99.75 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 99.71 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 99.68 | |
| PF10321 | 313 | 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept | 99.65 | |
| PF10317 | 292 | 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept | 99.26 | |
| PF11710 | 201 | Git3: G protein-coupled glucose receptor regulatin | 99.25 | |
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 99.03 | |
| PF10292 | 324 | 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c | 99.02 | |
| KOG4193|consensus | 610 | 98.99 | ||
| PF02118 | 275 | Srg: Srg family chemoreceptor; InterPro: IPR000609 | 98.88 | |
| PF10327 | 303 | 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept | 98.84 | |
| KOG4564|consensus | 473 | 98.79 | ||
| PF02101 | 405 | Ocular_alb: Ocular albinism type 1 protein; InterP | 98.79 | |
| PF10326 | 307 | 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept | 98.67 | |
| PF10318 | 302 | 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept | 98.57 | |
| PF10316 | 273 | 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep | 98.52 | |
| PF02117 | 328 | 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept | 98.38 | |
| PF10319 | 310 | 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept | 98.37 | |
| PF04789 | 305 | DUF621: Protein of unknown function (DUF621); Inte | 98.34 | |
| PF03125 | 365 | Sre: C. elegans Sre G protein-coupled chemorecepto | 98.33 | |
| PF00002 | 242 | 7tm_2: 7 transmembrane receptor (Secretin family); | 98.04 | |
| PF02076 | 283 | STE3: Pheromone A receptor; InterPro: IPR001499 G- | 97.35 | |
| PF01534 | 328 | Frizzled: Frizzled/Smoothened family membrane regi | 97.31 | |
| PF10322 | 307 | 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept | 97.21 | |
| PF11970 | 76 | Git3_C: G protein-coupled glucose receptor regulat | 97.21 | |
| PF06681 | 226 | DUF1182: Protein of unknown function (DUF1182); In | 96.32 | |
| PF02175 | 236 | 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept | 95.89 | |
| PF03383 | 153 | Serpentine_r_xa: Caenorhabditis serpentine recepto | 94.11 | |
| KOG4289|consensus | 2531 | 92.72 |
| >KOG4220|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=381.33 Aligned_cols=456 Identities=27% Similarity=0.418 Sum_probs=277.5
Q ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCcchhHHHHHHHHHHHHHHHHHHHHHHHHHHhhCcccccchhH
Q psy461 40 SVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSGRWIFGIIIC 119 (507)
Q Consensus 40 ~~~~~~~~~~~~~~~ii~~~gi~gN~lvi~~i~~~~~lr~~~~~ll~~LaisDll~~~~~~p~~i~~~~~~~~~~~~~~C 119 (507)
....++-++.+++..+++++.++||++|++.+.-.++|++..|+||++||++||++|++.+|++..+.+.+.|.+|...|
T Consensus 24 ~~~~~q~v~i~~v~~~lsLVTv~GNlLVmiSfKvnrqLqTVnNYfLfSLAcADliIG~~SMnl~t~Y~lmg~W~LG~~~C 103 (503)
T KOG4220|consen 24 RYETWQVVFIVVVTGSLSLVTVVGNLLVMISFKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTTYTLMGYWPLGPLVC 103 (503)
T ss_pred CccceEEEeeehhhhHHHHHhhhccEEEEEEEEecceeeeecceeehHHHHhhhhhheeechHHHHHHHHcccccchHHH
Confidence 34456667788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhHHHHHHHHHHHHHHHHHHHHHhhcccccccccccchhhhhHHHHHHHHHHHHhhccccccCCCc-cccCCCcc
Q psy461 120 KIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPE-VFEADTPC 198 (507)
Q Consensus 120 ~~~~~~~~~~~~~S~~~l~~IaidRy~aI~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~-~~~~~~~c 198 (507)
.++..+.++...+|++.++.|++|||+.|.+|+.|+.+.|++++..+|++.|++++++..|.++.|....+ .....+.|
T Consensus 104 dlWLalDYvaSNASVmNLLiISFDRYFsVTrPLtYrakRTtkrA~~MI~~AW~iSfiLWaPaIl~WqyivGkrTv~~~eC 183 (503)
T KOG4220|consen 104 DLWLALDYVASNASVMNLLIISFDRYFSVTRPLTYRAKRTTKRAGLMIGAAWVLSFVLWAPAILFWQYIVGKRTVPDGEC 183 (503)
T ss_pred HHHHHHHHHhhhhhhhhhheeeeecceeecccccccccccchHHHHHHHHHHHHHHHHHHHHHHhhHhheeeeecCCCce
Confidence 99999999999999999999999999999999999999999999999999999999999998887765433 34556678
Q ss_pred ccCCc--chhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhcchhcccccccccccccCCCCCCCccccCCC
Q psy461 199 QLTQQ--RGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQSPLEPESISSENDT 276 (507)
Q Consensus 199 ~~~~~--~~~~~~~~~~~~~ip~~vi~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (507)
..++. ........+..|.+|..+|+++|++|++..+++.+..........+.........++..........++..+.
T Consensus 184 ~iQFlsnp~iTfGTAiAAFYlPVtiM~~LY~rIyret~kR~k~~~~lq~s~~~~~~~~~~~~~~~~~~~~s~r~~p~~~~ 263 (503)
T KOG4220|consen 184 YIQFLSNPAITFGTAIAAFYLPVTIMTILYWRIYRETRKRQKELAKLQASLPSFSAIKLSPESPKGDSKSSGRSSPSEEG 263 (503)
T ss_pred EEEeecCceeehhHHHHHHHhhHHHHHHHHHHHHHHHHHHHHhhhhcccccccccccccCcccccccccCCCCCCCcccc
Confidence 77653 3345566778899999999999999999999988876655322211111111111100000000000010100
Q ss_pred CCCccccccccccchhhcccCCCCCCCccccccccccCCc-cccccccccchhc--cccCC---CCccceeecCCCcccc
Q psy461 277 KSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSM-TDIQDLSSSSNKI--AARND---NMGEFVHINNNETTFT 350 (507)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~ 350 (507)
.+.+..+.... ..+....+ .....+.....+.+ ....+.....-++ .+..+ ....+.+.+...++..
T Consensus 264 ~~~~~~~~~~~-~~k~ps~~------~~~~~~~s~~edsd~~~~~s~~~s~~~~~~se~~~~~~v~~~~~~~~~~~D~~~ 336 (503)
T KOG4220|consen 264 KREPLTNGCIS-NSKAPSLT------PTESWKPSEKEDSDESSSESLTSSPLERPGSELSEIEAVVAKMPANQRKVDEEG 336 (503)
T ss_pred ccccCCCCccc-cccCcccC------CccCCCCccccccccccccccccCCccccccccccccceeccCCCCcCCCCccc
Confidence 11111111000 00000000 00000000000000 0000000000000 00000 0000000000001000
Q ss_pred c-cccccccccccccCCCCCCCCCCCCcCCCCCCCCCccccccccccchhhccCCCh----hhHHHHHHHHHhhhhHHHH
Q psy461 351 N-KTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPST----QVVKQFIEEKQKISLSKER 425 (507)
Q Consensus 351 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 425 (507)
. ...+.......+.+++..+....-......+.+...+..+..+ .++ ..+.+. ...+.+.+++++-...+|+
T Consensus 337 ~~~~i~i~~~~~~p~s~sc~p~~~~t~~~~~s~~ns~~gk~r~~~-~~~--~~~~~~kkf~~~~r~q~~k~k~~~~~rEr 413 (503)
T KOG4220|consen 337 LNTLIQIPTDQMLPKSDSCVPIFSATDTDKTTDTNSGAGKRRAGP-VAR--KTGLDYKKFAKRARSQSRKKKKMSLVRER 413 (503)
T ss_pred cccccccccccCCCCCCcccccccccccccCCccCccccccccCc-ccc--ccchhhhhhhhhhhhhhhhhcchhhHHHH
Confidence 0 0011111111011111111000000000000000000000100 000 000000 1111122222233348999
Q ss_pred HHHHHHHHHHHHHHhhchhHHHHHhhccccCCccCchhHHHHHHHHHhhhcchhhHHHHhhcHHHHHHHHHHHHhhhhcc
Q psy461 426 RAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVSLSR 505 (507)
Q Consensus 426 r~~k~l~~i~~~f~i~w~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~NPiIY~~~n~~fR~~~~~l~~~~~~~~ 505 (507)
|++|++.+|.+.|++||.||.|+.++..++.++ ....+..+..||.|+||.+||+.|.+.|..||+.+++++.|...++
T Consensus 414 KAAkTLsAILlAFIiTWtPYNImVlv~tFC~~C-iP~tlW~~gYwLCYINSTiNP~CYALCNatFrkTfk~lL~Cr~~~~ 492 (503)
T KOG4220|consen 414 KAAKTLSAILLAFILTWTPYNIMVLVNTFCKNC-IPETLWTFGYWLCYINSTINPLCYALCNATFRKTFKRLLLCRWKKR 492 (503)
T ss_pred HHHHHHHHHHHHHHHHcccceeeeehHhhcccc-cchhHhhhhhheeeecccccHHHHHHHhHHHHHHHHHhheeeeccc
Confidence 999999999999999999999999999998865 5677888999999999999999999999999999999997766554
Q ss_pred c
Q psy461 506 E 506 (507)
Q Consensus 506 ~ 506 (507)
+
T Consensus 493 ~ 493 (503)
T KOG4220|consen 493 R 493 (503)
T ss_pred c
Confidence 3
|
|
| >KOG4219|consensus | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] | Back alignment and domain information |
|---|
| >PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4193|consensus | Back alignment and domain information |
|---|
| >PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4564|consensus | Back alignment and domain information |
|---|
| >PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes | Back alignment and domain information |
|---|
| >PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity | Back alignment and domain information |
|---|
| >PF03125 Sre: C | Back alignment and domain information |
|---|
| >PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02076 STE3: Pheromone A receptor; InterPro: IPR001499 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] | Back alignment and domain information |
|---|
| >PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF11970 Git3_C: G protein-coupled glucose receptor regulating Gpa2 C-term; InterPro: IPR022596 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans | Back alignment and domain information |
|---|
| >PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF03383 Serpentine_r_xa: Caenorhabditis serpentine receptor-like protein, class xa; InterPro: IPR005047 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 507 | ||||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 4e-29 | ||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 1e-12 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 2e-28 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 2e-15 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 2e-28 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 5e-15 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 3e-28 | ||
| 3p0g_A | 501 | Structure Of A Nanobody-Stabilized Active State Of | 1e-12 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 3e-28 | ||
| 3kj6_A | 366 | Crystal Structure Of A Methylated Beta2 Adrenergic | 2e-12 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 3e-28 | ||
| 2rh1_A | 500 | High Resolution Crystal Structure Of Human B2-Adren | 1e-12 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 4e-28 | ||
| 2r4r_A | 365 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 2e-12 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 4e-28 | ||
| 3d4s_A | 490 | Cholesterol Bound Form Of Human Beta2 Adrenergic Re | 2e-12 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 7e-28 | ||
| 2r4s_A | 342 | Crystal Structure Of The Human Beta2 Adrenoceptor L | 3e-12 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 8e-28 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 6e-13 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 3e-27 | ||
| 3pds_A | 458 | Irreversible Agonist-Beta2 Adrenoceptor Complex Len | 2e-12 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 6e-27 | ||
| 3pbl_A | 481 | Structure Of The Human Dopamine D3 Receptor In Comp | 1e-19 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 7e-25 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 3e-08 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 2e-24 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 3e-11 | ||
| 3rze_A | 452 | Structure Of The Human Histamine H1 Receptor In Com | 1e-19 | ||
| 4eiy_A | 447 | Crystal Structure Of The Chimeric Protein Of A2aar- | 2e-13 | ||
| 4eiy_A | 447 | Crystal Structure Of The Chimeric Protein Of A2aar- | 2e-09 | ||
| 3vg9_A | 326 | Crystal Structure Of Human Adenosine A2a Receptor W | 6e-13 | ||
| 3vg9_A | 326 | Crystal Structure Of Human Adenosine A2a Receptor W | 4e-09 | ||
| 3eml_A | 488 | The 2.6 A Crystal Structure Of A Human A2a Adenosin | 7e-13 | ||
| 3eml_A | 488 | The 2.6 A Crystal Structure Of A Human A2a Adenosin | 2e-08 | ||
| 2ydo_A | 325 | Thermostabilised Human A2a Receptor With Adenosine | 1e-12 | ||
| 2ydo_A | 325 | Thermostabilised Human A2a Receptor With Adenosine | 4e-09 | ||
| 3pwh_A | 329 | Thermostabilised Adenosine A2a Receptor Length = 32 | 2e-12 | ||
| 3pwh_A | 329 | Thermostabilised Adenosine A2a Receptor Length = 32 | 2e-08 | ||
| 4dkl_A | 464 | Crystal Structure Of The Mu-Opioid Receptor Bound T | 3e-11 | ||
| 4djh_A | 480 | Structure Of The Human Kappa Opioid Receptor In Com | 1e-09 | ||
| 2ziy_A | 372 | Crystal Structure Of Squid Rhodopsin Length = 372 | 2e-09 | ||
| 2z73_A | 448 | Crystal Structure Of Squid Rhodopsin Length = 448 | 2e-09 | ||
| 4ej4_A | 461 | Structure Of The Delta Opioid Receptor Bound To Nal | 4e-09 | ||
| 4ea3_B | 434 | Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI | 9e-09 | ||
| 4ea3_B | 434 | Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI | 4e-04 | ||
| 2ks9_A | 364 | Solution Conformation Of Substance P In Water Compl | 1e-08 | ||
| 3oax_A | 349 | Crystal Structure Of Bovine Rhodopsin With Beta-Ion | 4e-07 | ||
| 1jfp_A | 348 | Structure Of Bovine Rhodopsin (Dark Adapted) Length | 4e-07 | ||
| 2x72_A | 349 | Crystal Structure Of The Constitutively Active E113 | 4e-07 | ||
| 2j4y_A | 349 | Crystal Structure Of A Rhodopsin Stabilizing Mutant | 5e-07 | ||
| 3c9m_A | 348 | Structure Of A Mutant Bovine Rhodopsin In Hexagonal | 5e-07 | ||
| 4a4m_A | 349 | Crystal Structure Of The Light-Activated Constituti | 6e-07 | ||
| 3v2w_A | 520 | Crystal Structure Of A Lipid G Protein-Coupled Rece | 1e-06 | ||
| 3vw7_A | 484 | Crystal Structure Of Human Protease-Activated Recep | 2e-05 | ||
| 2lnl_A | 296 | Structure Of Human Cxcr1 In Phospholipid Bilayers L | 1e-04 | ||
| 1hll_A | 32 | Nmr Structure Of T3-I2, A 32 Residue Peptide From T | 6e-04 |
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
|
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3P0G|A Chain A, Structure Of A Nanobody-Stabilized Active State Of The Beta2 Adrenoceptor Length = 501 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|3KJ6|A Chain A, Crystal Structure Of A Methylated Beta2 Adrenergic Receptor- Fab Complex Length = 366 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|2RH1|A Chain A, High Resolution Crystal Structure Of Human B2-Adrenergic G Protein- Coupled Receptor Length = 500 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|2R4R|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 365 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|3D4S|A Chain A, Cholesterol Bound Form Of Human Beta2 Adrenergic Receptor. Length = 490 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|2R4S|A Chain A, Crystal Structure Of The Human Beta2 Adrenoceptor Length = 342 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|3PDS|A Chain A, Irreversible Agonist-Beta2 Adrenoceptor Complex Length = 458 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|3PBL|A Chain A, Structure Of The Human Dopamine D3 Receptor In Complex With Eticlopride Length = 481 | Back alignment and structure |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|3RZE|A Chain A, Structure Of The Human Histamine H1 Receptor In Complex With Doxepin Length = 452 | Back alignment and structure |
| >pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 | Back alignment and structure |
| >pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 | Back alignment and structure |
| >pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 | Back alignment and structure |
| >pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 | Back alignment and structure |
| >pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 | Back alignment and structure |
| >pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 | Back alignment and structure |
| >pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 | Back alignment and structure |
| >pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 | Back alignment and structure |
| >pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 | Back alignment and structure |
| >pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 | Back alignment and structure |
| >pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 | Back alignment and structure |
| >pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 | Back alignment and structure |
| >pdb|2ZIY|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 372 | Back alignment and structure |
| >pdb|2Z73|A Chain A, Crystal Structure Of Squid Rhodopsin Length = 448 | Back alignment and structure |
| >pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 | Back alignment and structure |
| >pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 | Back alignment and structure |
| >pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 | Back alignment and structure |
| >pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 | Back alignment and structure |
| >pdb|3OAX|A Chain A, Crystal Structure Of Bovine Rhodopsin With Beta-Ionone Length = 349 | Back alignment and structure |
| >pdb|1JFP|A Chain A, Structure Of Bovine Rhodopsin (Dark Adapted) Length = 348 | Back alignment and structure |
| >pdb|2X72|A Chain A, Crystal Structure Of The Constitutively Active E113q,N2c, D282c Rhodopsin Mutant With Bound Galphact Peptide Length = 349 | Back alignment and structure |
| >pdb|2J4Y|A Chain A, Crystal Structure Of A Rhodopsin Stabilizing Mutant Expressed In Mammalian Cells Length = 349 | Back alignment and structure |
| >pdb|3C9M|A Chain A, Structure Of A Mutant Bovine Rhodopsin In Hexagonal Crystal Form Length = 348 | Back alignment and structure |
| >pdb|4A4M|A Chain A, Crystal Structure Of The Light-Activated Constitutively Active N2c,M257y,D282c Rhodopsin Mutant In Complex With A Peptide Resembling The C-Terminus Of The Galpha-Protein Subunit (Gact) Length = 349 | Back alignment and structure |
| >pdb|3V2W|A Chain A, Crystal Structure Of A Lipid G Protein-Coupled Receptor At 3.35a Length = 520 | Back alignment and structure |
| >pdb|3VW7|A Chain A, Crystal Structure Of Human Protease-Activated Receptor 1 (Par1) Bound With Antagonist Vorapaxar At 2.2 Angstrom Length = 484 | Back alignment and structure |
| >pdb|2LNL|A Chain A, Structure Of Human Cxcr1 In Phospholipid Bilayers Length = 296 | Back alignment and structure |
| >pdb|1HLL|A Chain A, Nmr Structure Of T3-I2, A 32 Residue Peptide From The Alpha- 2a Adrenergic Receptor Length = 32 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 507 | |||
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 1e-135 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 1e-132 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 1e-132 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 1e-132 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 1e-128 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 6e-99 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 7e-88 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 5e-29 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 3e-85 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 1e-27 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 1e-81 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 3e-27 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 3e-59 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-46 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 3e-11 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 2e-46 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 8e-09 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 4e-43 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 4e-13 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 1e-36 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 3e-18 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 2e-31 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 2e-09 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 1e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-04 |
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-135
Identities = 109/465 (23%), Positives = 190/465 (40%), Gaps = 35/465 (7%)
Query: 42 PEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLP 101
+E + ++ +L + TIIGNI+V++S+ + L+ V N+F+ SLA ADL + +F +
Sbjct: 19 KTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMN 78
Query: 102 LSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIK 161
L +Y + G W G ++C +WL D + AS++NL I+ DRY+ +T PL Y +RT K
Sbjct: 79 LYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTK 138
Query: 162 RVMMMIMYVWLLSALISSPPLIGWNDWPEVFEADTP---CQLTQQRGYVVYSSLGSFFIP 218
MMI W+LS ++ +P ++ W V + Q +++ +F++P
Sbjct: 139 MAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLP 198
Query: 219 LAIMTLVYVEIFLATKKRLRDRA-----KASKLNIVKQTTLHNVQKEVQSPLEPESISSE 273
+ IMT++Y I A+K R+ + +L I K T + + S+++
Sbjct: 199 VIIMTVLYWHISRASKSRINIFEMLRIDEGLRLKIYKDTEGYYTIGIGHLLTKSPSLNAA 258
Query: 274 NDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARN 333
K +K N + ++ +R +L N L +
Sbjct: 259 KSELDKAIGRNTNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRAALINM 318
Query: 334 DNMGEFVHINNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVK 393
+ + A + + N K +
Sbjct: 319 VFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSRWYNQTPNRAKRVITTFRTGTW---- 374
Query: 394 SEVSIVVIQAPSTQVVKQFIEEKQKISLSKERRAARTLGIIMGVFVFCWLPFFLMYVSLP 453
S+E++ RT+ I+ F+ W P+ +M +
Sbjct: 375 ----------------------DAYPPPSREKKVTRTILAILLAFIITWAPYNVMVLINT 412
Query: 454 FCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLL 498
FC C+ + + WL YINS INP Y + N F+K+FK LL
Sbjct: 413 FCA-PCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLL 456
|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A Length = 32 | Back alignment and structure |
|---|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 507 | |||
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 100.0 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 100.0 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 100.0 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 100.0 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 100.0 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 100.0 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 100.0 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 100.0 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 100.0 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 100.0 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 100.0 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 100.0 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 100.0 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 100.0 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 100.0 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 100.0 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 100.0 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 100.0 | |
| 2koe_A | 40 | Human cannabinoid receptor 1 - helix 7/8 peptide; | 98.64 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.48 | |
| 2ki9_A | 33 | Cannabinoid receptor 2; GPCR, G-protein coupled re | 97.95 | |
| 2lot_A | 64 | Apelin receptor; membrane protein; NMR {Homo sapie | 95.9 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 91.0 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 84.04 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 81.37 |
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=425.73 Aligned_cols=203 Identities=19% Similarity=0.331 Sum_probs=168.9
Q ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc---chhHHHHHHHHHHHHHHHHHHHHHHHHHHhh--Ccccc
Q psy461 40 SVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLR---IVQNFFIVSLAVADLTVAIFVLPLSLIYYLS--GRWIF 114 (507)
Q Consensus 40 ~~~~~~~~~~~~~~~ii~~~gi~gN~lvi~~i~~~~~lr---~~~~~ll~~LaisDll~~~~~~p~~i~~~~~--~~~~~ 114 (507)
+...+..++..++|++++++|++||+++++++.+.+++| +++|+|++|||++|++++++.+|+.+...+. +.|.+
T Consensus 26 ~~~~~~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~~~~w~~ 105 (510)
T 4grv_A 26 NTDIYSKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWVHHPWAF 105 (510)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCSSCSS
T ss_pred ChhHHHHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCEEh
Confidence 345567888899999999999999999999999876554 7889999999999999999999999887654 56999
Q ss_pred cchhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHhhcccccccccccchhhhhHHHHHHHHHHHHhhccccccCCCcc---
Q psy461 115 GIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPEV--- 191 (507)
Q Consensus 115 ~~~~C~~~~~~~~~~~~~S~~~l~~IaidRy~aI~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~~--- 191 (507)
|+.+|++..++..++..+|++++++||+|||+||++|++|+..+|++++..+++++|++++++++|++++++.....
T Consensus 106 g~~~C~~~~~~~~~~~~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~ 185 (510)
T 4grv_A 106 GDAGCRGYYFLRDACTYATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADG 185 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSS
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999998877643222
Q ss_pred -ccCCCccccCC----cchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q psy461 192 -FEADTPCQLTQ----QRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAK 242 (507)
Q Consensus 192 -~~~~~~c~~~~----~~~~~~~~~~~~~~ip~~vi~~~y~~I~~~l~~~~~~~~~ 242 (507)
......|.... ...|..+..++.|++|+++|+++|++|++.++++.+....
T Consensus 186 ~~~~~~~c~~~~~~~~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~~~~~~~~ 241 (510)
T 4grv_A 186 THPGGLVCTPIVDTATVKVVIQVNTFMSFLFPMLVISILNTVIANKLTVMVNIFEM 241 (510)
T ss_dssp CCGGGEEEEECSCHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHTSCTHHHH
T ss_pred CCCCccccccccccchhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 11222354433 2335566667788999999999999999999987655443
|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} | Back alignment and structure |
|---|
| >2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 507 | ||||
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 4e-19 | |
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 4e-15 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.6 bits (213), Expect = 4e-19
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 8/208 (3%)
Query: 30 PSAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLA 89
S F Y W+ + + LI+ N + + +K LR N+ +++LA
Sbjct: 21 RSPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLA 80
Query: 90 VADLTVAIFVLPLSLIYYLSGRWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAIT 149
VADL + +L L G ++FG C + L ++ +L +A++RY +
Sbjct: 81 VADLFMVFGGFTTTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVC 140
Query: 150 DPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGW-------NDWPEVFEADTPCQLTQ 202
P+ + +M + + W+++ ++PPL+GW + TP + T
Sbjct: 141 KPMSN-FRFGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETN 199
Query: 203 QRGYVVYSSLGSFFIPLAIMTLVYVEIF 230
+V+Y + F IPL ++ Y ++
Sbjct: 200 NESFVIYMFVVHFIIPLIVIFFCYGQLV 227
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 507 | |||
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 85.45 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-40 Score=319.74 Aligned_cols=299 Identities=20% Similarity=0.386 Sum_probs=241.8
Q ss_pred CCcccccccCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCcchhHHHHHHHHHHHHHHHHHHHHHHHHHHhhC
Q psy461 31 SAFFNNIEYSVPEWEAIITMICLSTLIIGTIIGNIMVVISVFTYKPLRIVQNFFIVSLAVADLTVAIFVLPLSLIYYLSG 110 (507)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~ii~~~gi~gN~lvi~~i~~~~~lr~~~~~ll~~LaisDll~~~~~~p~~i~~~~~~ 110 (507)
..|.....+-.++|...+..+++.+++++|++||+++++++.++|++|++.|+++++||++|++.++...|..+.....+
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~~~ 101 (348)
T d1u19a_ 22 SPFEAPQYYLAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHG 101 (348)
T ss_dssp CTTTSCCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHT
T ss_pred CCCCCCccccccHHHHHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 34444566677788888999999999999999999999999999999999999999999999999999999999888888
Q ss_pred cccccchhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHhhcccccccccccchhhhhHHHHHHHHHHHHhhccccccCCCc
Q psy461 111 RWIFGIIICKIWLTSDVLCCTASILNLCAIALDRYWAITDPLVYAQQRTIKRVMMMIMYVWLLSALISSPPLIGWNDWPE 190 (507)
Q Consensus 111 ~~~~~~~~C~~~~~~~~~~~~~S~~~l~~IaidRy~aI~~P~~y~~~~t~~~~~~~i~~~w~~s~~~~~~~~~~~~~~~~ 190 (507)
.|..+...|++..++..++..++++++++|++|||++|++|++|... ++++....++.+|.+++++.+++.++......
T Consensus 102 ~~~~~~~~c~~~~~~~~~~~~~s~~~l~~is~~R~~~i~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (348)
T d1u19a_ 102 YFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRF-GENHAIMGVAFTWVMALACAAPPLVGWSRYIP 180 (348)
T ss_dssp SCTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTCCSSSCCC-CHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEE
T ss_pred ccccCchhhhhhhhccccceeeecchhhhhhcccceeeecccccccc-ccccccccceeeehhhhheecccccccceecc
Confidence 89999999999999999999999999999999999999999998654 66777888888999999999998877665432
Q ss_pred cccCCCccccC--------CcchhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhcchhccccccccccccc
Q psy461 191 VFEADTPCQLT--------QQRGYVVYSSLGSFFIPLAIMTLVYVEIFLATKKRLRDRAKASKLNIVKQTTLHNVQKEVQ 262 (507)
Q Consensus 191 ~~~~~~~c~~~--------~~~~~~~~~~~~~~~ip~~vi~~~y~~I~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (507)
. .....|... ....+..+...+.+++|+++++++|.++.++++++.++.
T Consensus 181 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~---------------------- 237 (348)
T d1u19a_ 181 E-GMQCSCGIDYYTPHEETNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQ---------------------- 237 (348)
T ss_dssp E-TTTTEEECCCSCCCGGGTHHHHHHHHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSS----------------------
T ss_pred C-CcccccccccccccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhhccccccc----------------------
Confidence 2 222222211 122244555566678999999999999876544321000
Q ss_pred CCCCCCCccccCCCCCCccccccccccchhhcccCCCCCCCccccccccccCCccccccccccchhccccCCCCccceee
Q psy461 263 SPLEPESISSENDTKSGKHKNKKRKKTKKKNVQKNNNNNNNSFLRPVLINEDSMTDIQDLSSSSNKIAARNDNMGEFVHI 342 (507)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (507)
T Consensus 238 -------------------------------------------------------------------------------- 237 (348)
T d1u19a_ 238 -------------------------------------------------------------------------------- 237 (348)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCccccccccccccccccccCCCCCCCCCCCCcCCCCCCCCCccccccccccchhhccCCChhhHHHHHHHHHhhhhH
Q psy461 343 NNNETTFTNKTISDDISLASIKSDKKPNNGNGCHVKTPVPHELNLKSTSVKSEVSIVVIQAPSTQVVKQFIEEKQKISLS 422 (507)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (507)
+......+
T Consensus 238 ------------------------------------------------------------------------~~~~~~~~ 245 (348)
T d1u19a_ 238 ------------------------------------------------------------------------QESATTQK 245 (348)
T ss_dssp ------------------------------------------------------------------------CSSSHHHH
T ss_pred ------------------------------------------------------------------------chhhhhHH
Confidence 00011235
Q ss_pred HHHHHHHHHHHHHHHHHhhchhHHHHHhhccccCCccCchhHHHHHHHHHhhhcchhhHHHHhhcHHHHHHHHHHHHhhh
Q psy461 423 KERRAARTLGIIMGVFVFCWLPFFLMYVSLPFCDTCCMSDRLINFITWLGYINSGINPIIYTIFNLDFRKSFKRLLNKVS 502 (507)
Q Consensus 423 ~~~r~~k~l~~i~~~f~i~w~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~~NPiIY~~~n~~fR~~~~~l~~~~~ 502 (507)
+++|++|++++++++|++||+|+.++.++....+.......+..+..+++++|+++||+||+++|++||++++++++|.+
T Consensus 246 ~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~~~~~~~~~~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~~~~~l~c~~ 325 (348)
T d1u19a_ 246 AEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNCMVTTLCCGK 325 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSCCCHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHHHHHHHTSSC
T ss_pred HHhhHhheEEEeehHHHHHhhHHHhhhheeeccCCccccHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHhCCCC
Confidence 67899999999999999999999998887776666666677778888999999999999999999999999999998666
Q ss_pred hcc
Q psy461 503 LSR 505 (507)
Q Consensus 503 ~~~ 505 (507)
++.
T Consensus 326 ~~~ 328 (348)
T d1u19a_ 326 NPL 328 (348)
T ss_dssp CCT
T ss_pred CCC
Confidence 543
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|